Aravive, Inc. — Form D

Aravive, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2014-02-20. The offering totals $55.0M, of which $55.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
Srinivas AkkarajuDirectorPalo Alto, CA
JEFFREY CLELANDDirectorBALTIMORE, MD
Francesco De RubertisDirectorCharlottesville, VA
Michael DybbsDirectorHalf Moon Bay, CA
Edmon JenningsDirectorRedwood City, CA
Shahzad MalikDirectorSan Diego, CA
Jay ShepardDirectorDallas, TX
Anthony SunDirectorApex, NC
Joshua BrummExecutive OfficerWaltham, MA
JEFFREY CLELANDExecutive OfficerBALTIMORE, MD
Paul WestbergExecutive OfficerRedwood City, CA
Fredric N EshelmanDirectorDurham, NC
Fredric N EshelmanExecutive OfficerDurham, NC
Kevin JohnsonDirectorSan Diego, CA
MICHAEL W ROGERSDirectorNEW YORK, NY
Rudy N HowardExecutive OfficerHouston, TX
Sigurd C KirkDirectorHouston, TX
Peter TC HoDirectorHouston, TX
Robert B GellerExecutive OfficerHouston, TX
Gail McIntyreDirectorHouston, TX
Gail McIntyreExecutive OfficerHouston, TX
Leonard Scott DoveExecutive OfficerHouston, TX
Eric B ZhangDirectorHouston, TX
Amato B GiacciaDirectorHouston, TX
John A HohneckerDirectorHouston, TX

Other filings by this issuer (7)

FiledFormOfferingSold
2022-10-28D$41.6M$41.6M
2014-02-19D$10.0M$10.0M
2013-10-11D$10.0M$10.0M
2013-07-22D$12.5M$12.5M
2013-01-28D$20.5M$8.0M
2013-01-28D$4.6M$4.6M
2011-03-09D$21.1M$14.4M

More